Monopar Therapeutics — Form 4
Filed September 28, 2026 · analyzed by the Insider Agent
4
▼ Likely negative
significance 54/100
What the filing says
Chief Executive Officer Robinson Chandler (MNPR) sold 58K shares (~$2.6M) on the open market (68% of holdings). Large sale — ~68% of holdings.
Why this rating
Large sale — ~68% of holdings.
See more from September 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.